Scopolamine
Scopolamine, Transderm Scop (scopolamine) is a small molecule pharmaceutical. Scopolamine was first approved as Transderm scop on 1982-01-01. It is used to treat colonic diseases, diverticulitis, dysentery, facial paralysis, and iridocyclitis amongst others in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M1 and muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M5.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
Scopolamine, Transderm scop
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| atenolol scopolamine | unapproved drug other | 2014-10-15 |
| donnatal | unapproved drug other | 2024-12-05 |
| donnatal extentabs | unapproved drug other | 2011-10-17 |
| kimite | unapproved drug other | 2018-12-12 |
| phenobarbital, hyoscyamine sulfate, atropine sulfate and scopolamine hydrobromide | unapproved drug other | 2023-01-10 |
| phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide | unapproved drug other | 2023-01-12 |
| phenohytro | unapproved drug other | 2025-09-22 |
| propranolol scopolamine | unapproved drug other | 2014-10-15 |
| quadrapax | unapproved drug other | 2011-09-13 |
| scopolamine | ANDA | 2025-08-23 |
Show 3 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A04: Antiemetics and antinauseants
— A04A: Antiemetics and antinauseants
— A04AD: Other antiemetics in atc
— A04AD01: Scopolamine
— A04AD51: Scopolamine, combinations
N: Nervous system drugs
— N05: Psycholeptics
— N05C: Hypnotics and sedatives
— N05CM: Other hypnotics and sedatives in atc
— N05CM05: Scopolamine
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01F: Mydriatics and cycloplegics
— S01FA: Anticholinergic mydriatics and cycloplegics
— S01FA02: Scopolamine
HCPCS
No data
Clinical
Clinical Trials
438 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 14 | 38 | 85 | 67 | 39 | 240 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 8 | 29 | 66 | 37 | 24 | 162 |
| Obstructive lung diseases | D008173 | — | — | 6 | 20 | 44 | 33 | 18 | 118 |
| Asthma | D001249 | EFO_0000270 | J45 | 2 | 11 | 10 | 6 | 5 | 34 |
| Healthy volunteers/patients | — | — | — | 20 | 1 | 1 | 2 | — | 24 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 3 | 2 | 8 | 2 | 1 | 16 |
| Nausea | D009325 | — | R11.0 | — | — | — | 3 | 6 | 9 |
| Pain | D010146 | EFO_0003843 | R52 | 1 | 1 | — | 4 | 3 | 9 |
| Vomiting | D014839 | — | R11.1 | — | — | — | 3 | 5 | 8 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | 2 | 4 | 6 |
Show 51 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motion sickness | D009041 | — | T75.3 | 2 | 4 | 9 | — | — | 13 |
| Dysmenorrhea | D004412 | — | N94.6 | — | — | 1 | — | 1 | 2 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | — | 1 | 2 |
| Colorectal neoplasms | D015179 | — | — | — | — | 1 | — | 1 | 2 |
| Obstetric labor | D007743 | — | — | — | — | 1 | — | 1 | 2 |
| Rectal neoplasms | D012004 | — | — | — | — | 1 | — | 1 | 2 |
| Cerebral palsy | D002547 | — | G80 | — | — | 1 | — | — | 1 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | — | 1 | 1 | — | — | 1 |
| Acute abdomen | D000006 | — | R10.0 | — | — | 1 | — | — | 1 |
| Labor pain | D048949 | — | — | — | 1 | 1 | — | — | 1 |
Show 7 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 2 | — | — | 1 | 3 |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | 3 | — | — | — | 3 |
| Gastrointestinal diseases | D005767 | — | — | — | 1 | — | — | 1 | 2 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | 1 | — | — | 1 | 2 |
| Acute pain | D059787 | — | R52 | — | 1 | — | — | 1 | 2 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | 1 | 2 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | 1 | 1 | — | — | — | 2 |
| Space motion sickness | D018489 | EFO_1001188 | — | — | 2 | — | — | — | 2 |
| Heart valve diseases | D006349 | EFO_0009551 | I08 | — | 1 | — | — | — | 1 |
| Sialorrhea | D012798 | — | K11.7 | 1 | 1 | — | — | — | 1 |
Show 9 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | — | G31.84 | 4 | — | — | — | 1 | 5 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 4 | — | — | — | — | 4 |
| Memory disorders | D008569 | — | — | 2 | — | — | — | 1 | 3 |
| Dementia | D003704 | EFO_0003862 | F03 | 3 | — | — | — | — | 3 |
| Organophosphate poisoning | D062025 | — | — | 1 | — | — | — | 1 | 2 |
| Poisoning | D011041 | EFO_0008546 | T65.91 | 1 | — | — | — | 1 | 2 |
| Hallucinations | D006212 | — | F06.0 | 1 | — | — | — | — | 1 |
| Psychotic disorders | D011618 | — | F20.81 | 1 | — | — | — | — | 1 |
| Renal colic | D056844 | EFO_1001412 | N23 | 1 | — | — | — | — | 1 |
| Nerve degeneration | D009410 | — | — | 1 | — | — | — | — | 1 |
Show 6 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Disease progression | D018450 | — | — | — | — | — | — | 1 | 1 |
| Rhytidoplasty | D015361 | — | — | — | — | — | — | 1 | 1 |
| Delirium | D003693 | — | R41.0 | — | — | — | — | 1 | 1 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | — | — | — | 1 | 1 |
| Diffuse scleroderma | D045743 | EFO_0000404 | — | — | — | — | — | 1 | 1 |
| Sclerosis | D012598 | — | — | — | — | — | — | 1 | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
| Bronchial hyperreactivity | D016535 | — | — | — | — | — | — | 1 | 1 |
| Choledocholithiasis | D042883 | EFO_1000865 | — | — | — | — | — | 1 | 1 |
Show 28 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Scopolamine |
| INN | — |
| Description | [(1S,5R)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate is a 3-hydroxy carboxylic acid. |
| Classification | Small molecule |
| Drug class | Antimuscarinic Deliriant Antiemetic Amnestic |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21 |
Identifiers
| PDB | — |
| CAS-ID | 51-34-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL569713 |
| ChEBI ID | 16794 |
| PubChem CID | 153311 |
| DrugBank | DB00747 |
| UNII ID | — |
Target
Alternate
CHRM2
CHRM2
CHRM4
CHRM4
CHRM5
CHRM5
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Scopolamine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 25,021 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,303 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use